Fundz

Qnovia, Inc. Raises $17 Million In Series A Funding To Advance Its Inhalable Therapeutics Pipeline

PRIVATESep 28, 2022

Amount Raised

$17 Million

Round Type

Series A

RichmondBiotechnologyHealth CareMedicalTherapeuticsPharmaceutical

Description

Qnovia, Inc. (Qnovia), a pharma company developing inhaled therapeutics with an initial focus on nicotine replacement therapy (NRT) and cardiopulmonary diseases, today announced it has raised $17 million in Series A funding. The financing was led by Blue Ledge Capital and included DG Ventures, Evolution VC Partners, Gaingels, TL Capital, and Vice Ventures.

Quick answer

Qnovia raised $17 Million in a Series A round, dated September 28, 2022. Qnovia is based in Richmond, Virginia, United States.

How much did Qnovia raise?
Qnovia raised $17 Million in a Series A round on September 28, 2022.
What does Qnovia do?
Qnovia was formerly known as Respira Technologies.
Where is Qnovia based and how big is it?
Qnovia is based in Richmond, Virginia, United States.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as Qnovia that raised within 45 days of this round, from Fundz verified event records.

  • NRx Pharmaceuticals raised $11M (Debt Financing) on November 7, 2022.
  • Abivax raised $49M (Funding Round) on September 2, 2022.
  • Lipidio Pharmaceuticals raised an undisclosed amount (Series A) on November 10, 2022.
  • MBX Biosciences, Inc. raised $47M on November 7, 2022.
  • Novadip Biosciences raised $39M (Funding Round) on November 4, 2022.
  • Tetra Bio-Pharma Inc. raised an undisclosed amount (Funding Round) on October 27, 2022.

Who to call at Qnovia, and when

A new round usually means Qnovia is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Qnovia raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Qnovia, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Qnovia. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Qnovia

Location

2920 WEST BROAD ST.

Richmond, Virginia, United States

About

Qnovia was formerly known as Respira Technologies. Qnovia, Inc. is a pharma company focused on developing and commercializing proprietary inhalation device technologies to improve patient outcomes. The company’s drug delivery platform, the RespiRx™, is the first orientation-agnostic, portable vibrating mesh nebulizer that effectively operates in any position held by the patient. Qnovia sees significant opportunity to utilize its drug delivery technologies to improve the treatment of Asthma, COPD, Vaccine Delivery, Pain Management, and several generic as well as select investigational new drugs. The company was founded by Mario Danek in 2018 to build cutting-edge drug delivery platforms that improve patient outcomes through superior device technologies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Qnovia raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Qnovia's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Qnovia raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.